Close Menu

cancer panel

GATC Biotech will sell and market Molecular Health's TreatmentMap next-generation sequencing-based tumor profiling platform around the world.

Despite the findings of the Hopkins study, for practical and economic reasons many diagnostic laboratories currently only sequence tumor samples or do not believe the tumor-normal approach is necessary.

The firm will launch an onsite version of its clinical decision support system this year and expects to add tumor profiling services next year.

The partners will use New Oncology's Neo platform to analyze therapeutically relevant alterations in cancer patients' DNA.

NEW YORK (GenomeWeb) — Researchers from the Vanderbilt University Medical Center have released a retrospective study showing that Foundation Medicine's FoundationOne test identified a potentially actionable mutation in the majority of the first 103 cancer patients to receive the test at the cente

NEW YORK (GenomeWeb) — OncoDNA, a clinical NGS provider affiliated with the Institute of Pathology and Genetics in Gosselies, Belgium, announced last week that it is providing targeted sequencing of metastatic breast cancer patients for a large international effort called AURORA, led by the Breas

Genewiz, a contract research organization specializing in sequencing and other genomic services, has announced that it is branching out into the clinical sequencing and personalized medicine space with two sequencing panels — a 25-gene general pharmacogenomic panel and a 35-gene

Ambry Genetics and GE Healthcare, who each released a new 26-gene sequencing service last week, have disclosed that both of their new services are based on Illumina's TruSight Tumor panel for somatic variant detection in solid tumors on the MiSeq platform.

Cynvenio Biosystems expects to gain CLIA certification this year for its circulating tumor cell recovery technology and sequencing service using the Ion Torrent PGM, which the company is already performing for several academic and pharmaceutical industry customers in the research

The University of Washington and the Seattle Cancer Care Alliance announced earlier this month that they are offering a new cancer sequencing service, called UW-OncoPlex, that targets hotspot regions and exons of 194 genes.

Pages

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.